No black box warning on record for Premarin

As of the latest FDA labeling reviewed, Premarin (CONJUGATED ESTROGENS) does not carry a black box warning. Standard warnings and precautions still apply — see the full Premarin medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS See BOXED WARNINGS . Premarin Intravenous for injection is indicated for short-term use. However, warnings, precautions and adverse reactions associated with oral Premarin treatment should be taken into account. 1. Cardiovascular Disorders An increased risk of stroke and DVT has been reported with estrogen-alone therapy. An increased risk of PE, DVT, stroke, and MI has been reported with

No black box warning on record for Premarin

Other warnings & precautions

WARNINGS See BOXED WARNINGS . Premarin Intravenous for injection is indicated for short-term use. However, warnings, precautions and adverse reactions associated with oral Premarin treatment should be taken into account. 1. Cardiovascular Disorders An increased risk of stroke and DVT has been reported with estrogen-alone therapy. An increased risk of PE, DVT, stroke, and MI has been reported with

Premarin Black Box Warning

No black box warning on record for Premarin

Other warnings & precautions

Premarin Black Box Warning

No black box warning on record for Premarin

Other warnings & precautions